EMR – Dividend Returns, History & Calculator

Dividend King 68 Years

Emerson Electric Co., a technology and software company, provides various solutions in the Americas, Asia, the Middle East, Africa, and Europe. It operates through Final Control, Measurement & Analytical, Discrete Automation, Safety & Productivity, Control Sys

...

Company Info

Symbol EMR

Company Emerson Electric Company

Sector Industrials

Industry Specialty Industrial Machinery

Website Visit

Market Cap $72,466.1M

Price Data

Price $128.79

Price Change +1.18

Price Change % +0.92%

Next Earnings Report Feb 4, 2026

Low (52W) $90.06

High (52W) $150.27

Dividend Data

Div Yield 1.72%

5Y Avg Yield 2.18%

Current Div $0.555

Payouts/Year 4

Annualized $2.220

Previous Div $0.528

Ex-date Nov 14, 2025

Dividend Pay Date Dec 10, 2025

Growth Rates

Chowder Number 3.0

DGR 1Y 1.7%

DGR 3Y 1.2%

DGR 5Y 1.3%

DGR 10Y 1.3%

Total Returns

TTR 1Y - With Specials 5.0%

TTR 3Y - With Specials 13.7%

TTR 1Y - No Specials 5.0%

TTR 3Y - No Specials 13.7%

Fair Value

Fair Value (P/E 10) $82.39

FV (P/E 10) % 56.0%

Fair Value (Peter Lynch) $32.12

FV (Peter Lynch) % 301.0%

Fair Value (Blended) $113.37

FV (Blended) % 14.0%

Financial Metrics

Revenue 1Y 3.0%

NPM 12.7%

CF/Share $5.51

ROE 9.4%

Current R 0.9x

Debt/Capital 30.0%

ROTC 8.1%

P/E 32.0x

P/BV 3.6x

PEG 3.47

📊 Financial data last updated: November 17, 2025 3:22 pm

Calculate your EMR Dividend Returns

Quickly and easily calculate EMR dividend yield using our EMR calculator. Adjust the fields below to see how your EMR investments snowball over time.

Initial Investment: The lump sum you’re investing on day 1. Share Price: The current market price of one share. Dividend Amount (per payout): Enter the dividend paid per share each payout (e.g., quarterly for many ETFs). Annual yield is computed from this and the selected frequency. Dividend Frequency: How often you receive dividends (e.g. quarterly). Dividend Growth Rate: The yearly increase in dividend payouts (as a percentage). Share Price Growth: Expected annual increase in share price over time. Extra Investment: The amount you invest regularly (e.g. each month). Extra Invest Frequency: How often your extra investment is made (e.g. monthly). Length of Investment: How long you plan to keep investing and compounding.

Show Idealized Scenario (Assumes all future extra investments and dividends are made on Day 1 and reinvested instantly — this creates a best-case scenario for compounding growth.)

Portfolio Growth Over Time

Data last updated: November 18, 2025 9:58 pm

Year-by-Year Portfolio Growth (Realistic DRIP Scenario)

Year	Start Balance	Start Shares	Share Price	Dividend / Share	Dividend Yield	Yield on Cost	Annual Dividend	Total Dividends	End Shares	End Balance
1	$10,000	79	$126.75	$0.56	1.75%	1.75%	$189	$189	90	$11,389
2	$12,511	90	$139.23	$0.56	1.62%	1.78%	$216	$406	100	$13,927
3	$15,298	100	$152.93	$0.57	1.50%	1.81%	$242	$647	109	$16,739
4	$18,387	109	$167.99	$0.58	1.38%	1.84%	$266	$914	118	$19,853
5	$21,808	118	$184.52	$0.59	1.28%	1.86%	$290	$1,204	126	$23,298
6	$25,591	126	$202.69	$0.60	1.18%	1.89%	$313	$1,517	134	$27,104
7	$29,772	134	$222.64	$0.61	1.09%	1.92%	$336	$1,852	141	$31,308
8	$34,390	141	$244.55	$0.62	1.01%	1.95%	$357	$2,210	147	$35,947
9	$39,485	147	$268.62	$0.63	0.94%	1.98%	$378	$2,587	153	$41,063
10	$45,105	153	$295.07	$0.64	0.87%	2.01%	$398	$2,986	158	$46,703

EMR Dividend History

Ex-Date	Payment Date	Amount	TTM Yield	Forward Yield	Price on Ex-Date
11/14/2025	11/14/2025	$0.555	1.68%	1.74%	$127.58
08/15/2025	08/15/2025	$0.528	1.60%	1.60%	$131.75
05/16/2025	05/16/2025	$0.528	1.75%	1.75%	$120.61
02/14/2025	02/14/2025	$0.528	1.71%	1.71%	$123.34
11/15/2024	11/15/2024	$0.528	1.66%	1.67%	$126.78
08/16/2024	08/16/2024	$0.525	2.04%	2.04%	$103.09
05/16/2024	05/16/2024	$0.525	1.86%	1.86%	$112.82
02/15/2024	02/15/2024	$0.525	1.98%	1.99%	$105.71
11/16/2023	11/16/2023	$0.525	2.38%	2.40%	$87.50
08/10/2023	08/10/2023	$0.520	2.18%	2.18%	$95.51
05/11/2023	05/11/2023	$0.520	2.53%	2.54%	$81.98
02/16/2023	02/16/2023	$0.520	2.42%	2.43%	$85.70
11/09/2022	11/09/2022	$0.520	2.29%	2.31%	$90.12
08/11/2022	08/11/2022	$0.515	2.35%	2.35%	$87.49
05/12/2022	05/12/2022	$0.515	2.48%	2.49%	$82.75
02/10/2022	02/10/2022	$0.515	2.11%	2.13%	$96.87
11/10/2021	11/10/2021	$0.515	2.09%	2.12%	$97.03
08/12/2021	08/12/2021	$0.505	1.94%	1.94%	$104.11
05/13/2021	05/13/2021	$0.505	2.13%	2.13%	$94.71
02/11/2021	02/11/2021	$0.505	2.36%	2.37%	$85.16

Page 1 of 1

EMR 10-yr Total Return ($10,000 invested)

This analysis of EMR demonstrates the power of dividend reinvestment over a 10-year period with a $10,000 initial investment. The dividend reinvestment strategy delivered a 14.1% CAGR, representing strong long-term performance. The DRIP strategy provided 19% more total return compared to collecting dividends as cash, highlighting the compounding effect of reinvestment.

With DRIP No DRIP

Date	With DRIP	No DRIP	DRIP Advantage	Dividend
2016-02-10	$10,104	$10,104	$0	$0.475
2016-05-11	$11,774	$11,757	$17	$0.475
2016-08-10	$12,009	$11,987	$22	$0.475
2016-11-08	$11,642	$11,631	$11	$0.480
2017-02-15	$14,564	$14,445	$119	$0.480
2017-05-10	$13,577	$13,501	$75	$0.480
2017-08-09	$13,941	$13,846	$94	$0.480
2017-11-16	$13,819	$13,732	$87	$0.485
2018-02-15	$16,854	$16,564	$290	$0.485
2018-05-10	$17,079	$16,773	$306	$0.485
2018-08-16	$17,667	$17,314	$353	$0.485
2018-11-15	$16,554	$16,296	$258	$0.490
2019-02-14	$16,111	$15,894	$217	$0.490
2019-05-16	$16,031	$15,821	$210	$0.490
2019-08-15	$13,892	$13,908	$-15	$0.490
2019-11-14	$18,035	$17,582	$452	$0.500
2020-02-13	$18,260	$17,781	$479	$0.500
2020-05-14	$13,452	$13,573	$-122	$0.500
2020-08-13	$17,816	$17,357	$459	$0.500
2020-11-12	$18,967	$18,348	$619	$0.505
2021-02-11	$21,889	$20,847	$1,043	$0.505
2021-05-13	$24,474	$23,043	$1,430	$0.505
2021-08-12	$27,033	$25,208	$1,826	$0.505
2021-11-10	$25,329	$23,773	$1,555	$0.515
2022-02-10	$25,421	$23,851	$1,570	$0.515
2022-05-12	$21,851	$20,878	$973	$0.515
2022-08-11	$23,239	$22,026	$1,212	$0.515
2022-11-09	$24,075	$22,715	$1,361	$0.520
2023-02-16	$23,033	$21,863	$1,171	$0.520
2023-05-11	$22,173	$21,163	$1,010	$0.520
2023-08-10	$25,973	$24,233	$1,740	$0.520
2023-11-16	$23,938	$22,598	$1,340	$0.525
2024-02-15	$29,063	$26,691	$2,372	$0.525
2024-05-16	$31,162	$28,359	$2,803	$0.525
2024-08-16	$28,620	$26,348	$2,272	$0.525
2024-11-15	$35,343	$31,639	$3,704	$0.528
2025-02-14	$34,532	$31,003	$3,529	$0.528
2025-05-16	$33,915	$30,522	$3,393	$0.528
2025-08-15	$37,196	$33,071	$4,125	$0.528
2025-11-14	$36,175	$32,281	$3,894	$0.555

Total Return with and without DRIP (EMR)

Over the selected period, investing $10,000 in EMR would grow to $48,183 with DRIP (381.8%), and $41,480 without DRIP (314.8%).

EMR Dividend Reinvestment Snowball

Investing $10,000 + $100/mo in EMR with historic price growth (9.84%) and dividend growth (1.57%) produces dramatically different outcomes depending on whether you reinvest dividends.

After 20 Years

Your Investment: $34,000

With DRIP

Portfolio: $155,947

Annual Dividend: $570

Yield on Cost: 1.68%

Total Dividends: $7,792

No DRIP

Portfolio: $143,540

Total Dividends: $7,083

After 30 Years

Your Investment: $46,000

With DRIP

Portfolio: $429,136

Annual Dividend: $717

Yield on Cost: 1.56%

Total Dividends: $14,188

No DRIP

Portfolio: $381,539

Total Dividends: $12,625

Milestones on the way

By year 13, the compounding really starts to show. Your total dividends collected reach $4,216 against a total investment of $25,600. At this point, your portfolio is throwing off $456 per year in dividends alone.

By year 17, the annual dividend climbs to around your initial contribution. For a starting investment of $10,000, the yearly dividend now sits at approximately $523, a powerful “income on autopilot” milestone.

After two decades, cumulative dividends total $7,792 versus $34,000 invested, nearly a 23% recovery of capital purely from income. Yield on cost reaches 1.68%.

At year 25, the income engine takes over. The portfolio’s annual dividend of $645 is greater than total contributions to date ($40,000), and cumulative dividends exceed $10,809.

By year 30, the DRIP snowball is in full force. Yearly income reaches $717, cumulative dividends total $14,188, and the DRIP portfolio value stands at $429,136, compared with $381,539 if dividends weren’t reinvested.

How we estimate these numbers

We use the latest calculator inputs for EMR, price $126.75, dividend per period $0.56 (4x/year), along with historic growth assumptions: price growth 9.84% and dividend growth 1.57% annually.

We simulate month by month for 30 years. Every month, a $100 contribution is added and converted to shares at that month’s price. Dividends are paid roughly evenly across the year based on the dividend frequency; in the DRIP path, each payout immediately buys additional shares at the then-current price. In the No-DRIP path, dividends accrue as cash. Prices grow using a monthly rate derived from the annual price growth. Dividends per share increase once per year at the annual dividend growth rate.

This model isn’t investment advice; it’s a simple, transparent framework that illustrates how reinvesting dividends can accelerate both income and total return over time.

Projected Future Returns & Dividends for EMR

Based on past 10-year performance, here are EMR growth metrics:

Share price CAGR of +8.84%

Dividend CAGR of +1.27%

Using EMR CAGR metrics, we can estimate that your initial $10,000 investment, over the next 10 years, should grow as follows:

	EMR (DRIP)	EMR (No DRIP)
Current Price	$126.75	$126.75
Start Shares	78.90	78.90
Start Value	$10,000	$10,000
After 10 years:
Final Share Count	88.92	78.90
Dividends Payment	$2.52	$2.52
Annual Dividends	$222	$199
Yield on cost	2.22%	1.99%
Share Price	$295.70	$295.70
Total Dividends	$2,000	$1,879
Final Value	$26,294	$25,208

Estimated Future Value + Dividends – EMR

Dividend History: Payments & Yield

Shows quarterly dividend payments with trailing yield and a 5-year rolling average overlay. Use the range pills to switch the visible period.

Yield Dividend

Date	Dividend	Share Price	Yield %	TTM Dividend	TTM Yield %
2016-02-10	$0.4750	$45.77	1.04%	$1.8900	4.13%
2016-05-11	$0.4750	$52.86	0.90%	$1.8950	3.58%
2016-08-10	$0.4750	$53.44	0.89%	$1.9000	3.56%
2016-11-08	$0.4800	$51.33	0.94%	$1.9050	3.71%
2017-02-15	$0.4800	$63.73	0.75%	$1.9100	3.00%
2017-05-10	$0.4800	$58.93	0.81%	$1.9150	3.25%
2017-08-09	$0.4800	$60.03	0.80%	$1.9200	3.20%
2017-11-16	$0.4850	$59.02	0.82%	$1.9250	3.26%
2018-02-15	$0.4850	$71.50	0.68%	$1.9300	2.70%
2018-05-10	$0.4850	$71.97	0.67%	$1.9350	2.69%
2018-08-16	$0.4850	$73.96	0.66%	$1.9400	2.62%
2018-11-15	$0.4900	$68.81	0.71%	$1.9450	2.83%
2019-02-14	$0.4900	$66.48	0.74%	$1.9500	2.93%
2019-05-16	$0.4900	$65.66	0.75%	$1.9550	2.98%
2019-08-15	$0.4900	$56.41	0.87%	$1.9600	3.47%
2019-11-14	$0.5000	$72.73	0.69%	$1.9700	2.71%
2020-02-13	$0.5000	$73.14	0.68%	$1.9800	2.71%
2020-05-14	$0.5000	$53.38	0.94%	$1.9900	3.73%
2020-08-13	$0.5000	$70.20	0.71%	$2.0000	2.85%
2020-11-12	$0.5050	$74.23	0.68%	$2.0050	2.70%
2021-02-11	$0.5050	$85.16	0.59%	$2.0100	2.36%
2021-05-13	$0.5050	$94.71	0.53%	$2.0150	2.13%
2021-08-12	$0.5050	$104.11	0.49%	$2.0200	1.94%
2021-11-10	$0.5150	$97.03	0.53%	$2.0300	2.09%
2022-02-10	$0.5150	$96.87	0.53%	$2.0400	2.11%
2022-05-12	$0.5150	$82.75	0.62%	$2.0500	2.48%
2022-08-11	$0.5150	$87.49	0.59%	$2.0600	2.35%
2022-11-09	$0.5200	$90.12	0.58%	$2.0650	2.29%
2023-02-16	$0.5200	$85.70	0.61%	$2.0700	2.42%
2023-05-11	$0.5200	$81.98	0.63%	$2.0750	2.53%
2023-08-10	$0.5200	$95.51	0.54%	$2.0800	2.18%
2023-11-16	$0.5250	$87.50	0.60%	$2.0850	2.38%
2024-02-15	$0.5250	$105.71	0.50%	$2.0900	1.98%
2024-05-16	$0.5250	$112.82	0.47%	$2.0950	1.86%
2024-08-16	$0.5250	$103.09	0.51%	$2.1000	2.04%
2024-11-15	$0.5280	$126.78	0.42%	$2.1030	1.66%
2025-02-14	$0.5280	$123.34	0.43%	$2.1060	1.71%
2025-05-16	$0.5280	$120.61	0.44%	$2.1090	1.75%
2025-08-15	$0.5280	$131.75	0.40%	$2.1120	1.60%
2025-11-14	$0.5550	$127.58	0.44%	$2.1390	1.68%

Dividend Growth

Lifetime quarterly dividend amounts, with range controls for 1Y/2Y/5Y/10Y. Useful to visualize the cadence and pace of dividend increases over time.

Dividend

Date	Dividend	Share Price	Yield %	QoQ Change
2016-02-10	$0.4750	$45.77	1.04%	N/A
2016-05-11	$0.4750	$52.86	0.90%	+0.0%
2016-08-10	$0.4750	$53.44	0.89%	+0.0%
2016-11-08	$0.4800	$51.33	0.94%	+1.1%
2017-02-15	$0.4800	$63.73	0.75%	+0.0%
2017-05-10	$0.4800	$58.93	0.81%	+0.0%
2017-08-09	$0.4800	$60.03	0.80%	+0.0%
2017-11-16	$0.4850	$59.02	0.82%	+1.0%
2018-02-15	$0.4850	$71.50	0.68%	+0.0%
2018-05-10	$0.4850	$71.97	0.67%	+0.0%
2018-08-16	$0.4850	$73.96	0.66%	+0.0%
2018-11-15	$0.4900	$68.81	0.71%	+1.0%
2019-02-14	$0.4900	$66.48	0.74%	+0.0%
2019-05-16	$0.4900	$65.66	0.75%	+0.0%
2019-08-15	$0.4900	$56.41	0.87%	+0.0%
2019-11-14	$0.5000	$72.73	0.69%	+2.0%
2020-02-13	$0.5000	$73.14	0.68%	+0.0%
2020-05-14	$0.5000	$53.38	0.94%	+0.0%
2020-08-13	$0.5000	$70.20	0.71%	+0.0%
2020-11-12	$0.5050	$74.23	0.68%	+1.0%
2021-02-11	$0.5050	$85.16	0.59%	+0.0%
2021-05-13	$0.5050	$94.71	0.53%	+0.0%
2021-08-12	$0.5050	$104.11	0.49%	+0.0%
2021-11-10	$0.5150	$97.03	0.53%	+2.0%
2022-02-10	$0.5150	$96.87	0.53%	+0.0%
2022-05-12	$0.5150	$82.75	0.62%	+0.0%
2022-08-11	$0.5150	$87.49	0.59%	+0.0%
2022-11-09	$0.5200	$90.12	0.58%	+1.0%
2023-02-16	$0.5200	$85.70	0.61%	+0.0%
2023-05-11	$0.5200	$81.98	0.63%	+0.0%
2023-08-10	$0.5200	$95.51	0.54%	+0.0%
2023-11-16	$0.5250	$87.50	0.60%	+1.0%
2024-02-15	$0.5250	$105.71	0.50%	+0.0%
2024-05-16	$0.5250	$112.82	0.47%	+0.0%
2024-08-16	$0.5250	$103.09	0.51%	+0.0%
2024-11-15	$0.5280	$126.78	0.42%	+0.6%
2025-02-14	$0.5280	$123.34	0.43%	+0.0%
2025-05-16	$0.5280	$120.61	0.44%	+0.0%
2025-08-15	$0.5280	$131.75	0.40%	+0.0%
2025-11-14	$0.5550	$127.58	0.44%	+5.1%

Dividend Payments & Yield

Quarterly dividends with TTM yield and a 5âyear rolling average overlay. Helps compare current yield versus recent history across different ranges.

Dividend 5-yr Rolling AVG Yield

Date	Dividend	TTM Yield	5-yr Avg Yield	YoY Change
2016-02-10	$0.4750	4.13%	4.13%	N/A
2016-05-11	$0.4750	3.58%	3.86%	N/A
2016-08-10	$0.4750	3.56%	3.76%	N/A
2016-11-08	$0.4800	3.71%	3.75%	N/A
2017-02-15	$0.4800	3.00%	3.60%	1.1%
2017-05-10	$0.4800	3.25%	3.54%	1.1%
2017-08-09	$0.4800	3.20%	3.49%	1.1%
2017-11-16	$0.4850	3.26%	3.46%	1.1%
2018-02-15	$0.4850	2.70%	3.38%	1.1%
2018-05-10	$0.4850	2.69%	3.31%	1.0%
2018-08-16	$0.4850	2.62%	3.25%	1.0%
2018-11-15	$0.4900	2.83%	3.21%	1.0%
2019-02-14	$0.4900	2.93%	3.19%	1.0%
2019-05-16	$0.4900	2.98%	3.17%	1.0%
2019-08-15	$0.4900	3.47%	3.19%	1.0%
2019-11-14	$0.5000	2.71%	3.16%	1.3%
2020-02-13	$0.5000	2.71%	3.14%	1.5%
2020-05-14	$0.5000	3.73%	3.17%	1.8%
2020-08-13	$0.5000	2.85%	3.15%	2.0%
2020-11-12	$0.5050	2.70%	3.13%	1.8%
2021-02-11	$0.5050	2.36%	3.04%	1.5%
2021-05-13	$0.5050	2.13%	2.97%	1.3%
2021-08-12	$0.5050	1.94%	2.89%	1.0%
2021-11-10	$0.5150	2.09%	2.81%	1.3%
2022-02-10	$0.5150	2.11%	2.76%	1.5%
2022-05-12	$0.5150	2.48%	2.72%	1.7%
2022-08-11	$0.5150	2.35%	2.68%	2.0%
2022-11-09	$0.5200	2.29%	2.63%	1.7%
2023-02-16	$0.5200	2.42%	2.62%	1.5%
2023-05-11	$0.5200	2.53%	2.61%	1.2%
2023-08-10	$0.5200	2.18%	2.59%	1.0%
2023-11-16	$0.5250	2.38%	2.57%	1.0%
2024-02-15	$0.5250	1.98%	2.52%	1.0%
2024-05-16	$0.5250	1.86%	2.46%	1.0%
2024-08-16	$0.5250	2.04%	2.39%	1.0%
2024-11-15	$0.5280	1.66%	2.34%	0.9%
2025-02-14	$0.5280	1.71%	2.29%	0.8%
2025-05-16	$0.5280	1.75%	2.19%	0.7%
2025-08-15	$0.5280	1.60%	2.13%	0.6%
2025-11-14	$0.5550	1.68%	2.08%	1.7%

EMR Dividend History

Ex-Date	Payment Date	Amount	TTM Yield	Forward Yield	Price on Ex-Date
11/14/2025	11/14/2025	$0.555	1.68%	1.74%	$127.58
08/15/2025	08/15/2025	$0.528	1.60%	1.60%	$131.75
05/16/2025	05/16/2025	$0.528	1.75%	1.75%	$120.61
02/14/2025	02/14/2025	$0.528	1.71%	1.71%	$123.34
11/15/2024	11/15/2024	$0.528	1.66%	1.67%	$126.78
08/16/2024	08/16/2024	$0.525	2.04%	2.04%	$103.09
05/16/2024	05/16/2024	$0.525	1.86%	1.86%	$112.82
02/15/2024	02/15/2024	$0.525	1.98%	1.99%	$105.71
11/16/2023	11/16/2023	$0.525	2.38%	2.40%	$87.50
08/10/2023	08/10/2023	$0.520	2.18%	2.18%	$95.51
05/11/2023	05/11/2023	$0.520	2.53%	2.54%	$81.98
02/16/2023	02/16/2023	$0.520	2.42%	2.43%	$85.70
11/09/2022	11/09/2022	$0.520	2.29%	2.31%	$90.12
08/11/2022	08/11/2022	$0.515	2.35%	2.35%	$87.49
05/12/2022	05/12/2022	$0.515	2.48%	2.49%	$82.75
02/10/2022	02/10/2022	$0.515	2.11%	2.13%	$96.87
11/10/2021	11/10/2021	$0.515	2.09%	2.12%	$97.03
08/12/2021	08/12/2021	$0.505	1.94%	1.94%	$104.11
05/13/2021	05/13/2021	$0.505	2.13%	2.13%	$94.71
02/11/2021	02/11/2021	$0.505	2.36%	2.37%	$85.16
11/12/2020	11/12/2020	$0.505	2.70%	2.72%	$74.23
08/13/2020	08/13/2020	$0.500	2.85%	2.85%	$70.20
05/14/2020	05/14/2020	$0.500	3.73%	3.75%	$53.38
02/13/2020	02/13/2020	$0.500	2.71%	2.73%	$73.14
11/14/2019	11/14/2019	$0.500	2.71%	2.75%	$72.73
08/15/2019	08/15/2019	$0.490	3.47%	3.47%	$56.41
05/16/2019	05/16/2019	$0.490	2.98%	2.99%	$65.66
02/14/2019	02/14/2019	$0.490	2.93%	2.95%	$66.48
11/15/2018	11/15/2018	$0.490	2.83%	2.85%	$68.81
08/16/2018	08/16/2018	$0.485	2.62%	2.62%	$73.96
05/10/2018	05/10/2018	$0.485	2.69%	2.70%	$71.97
02/15/2018	02/15/2018	$0.485	2.70%	2.71%	$71.50
11/16/2017	11/16/2017	$0.485	3.26%	3.29%	$59.02
08/09/2017	08/09/2017	$0.480	3.20%	3.20%	$60.03
05/10/2017	05/10/2017	$0.480	3.25%	3.26%	$58.93
02/15/2017	02/15/2017	$0.480	3.00%	3.01%	$63.73
11/08/2016	11/08/2016	$0.480	3.71%	3.74%	$51.33
08/10/2016	08/10/2016	$0.475	3.56%	3.56%	$53.44
05/11/2016	05/11/2016	$0.475	3.58%	3.59%	$52.86
02/10/2016	02/10/2016	$0.475	4.13%	4.15%	$45.77
11/10/2015	11/10/2015	$0.475	3.94%	3.98%	$47.79
08/12/2015	08/12/2015	$0.470	3.83%	3.83%	$49.08
05/13/2015	05/13/2015	$0.470	3.05%	3.12%	$60.34
02/11/2015	02/11/2015	$0.470	3.12%	3.26%	$57.69
11/12/2014	11/12/2014	$0.470	2.75%	2.94%	$64.05
08/13/2014	08/13/2014	$0.430	2.73%	2.73%	$63.05
05/14/2014	05/14/2014	$0.430	2.53%	2.56%	$67.30
02/12/2014	02/12/2014	$0.430	2.58%	2.64%	$65.11
11/13/2013	11/13/2013	$0.430	2.48%	2.57%	$66.85
08/14/2013	08/14/2013	$0.410	2.64%	2.64%	$62.07
05/15/2013	05/15/2013	$0.410	2.79%	2.80%	$58.50
02/13/2013	02/13/2013	$0.410	2.79%	2.82%	$58.10
11/14/2012	11/14/2012	$0.410	3.33%	3.39%	$48.37
08/15/2012	08/15/2012	$0.400	3.11%	3.11%	$51.52
05/09/2012	05/09/2012	$0.400	3.21%	3.32%	$48.16
02/15/2012	02/15/2012	$0.400	2.92%	3.14%	$50.97
11/08/2011	11/08/2011	$0.400	2.75%	3.07%	$52.13
08/10/2011	08/10/2011	$0.345	3.29%	3.29%	$41.89
05/11/2011	05/11/2011	$0.345	2.51%	2.53%	$54.49
02/09/2011	02/09/2011	$0.345	2.23%	2.26%	$60.99
11/09/2010	11/09/2010	$0.345	2.40%	2.46%	$56.18
08/11/2010	08/11/2010	$0.335	2.77%	2.77%	$48.33
05/12/2010	05/12/2010	$0.335	2.66%	2.67%	$50.27
02/10/2010	02/10/2010	$0.335	2.93%	2.95%	$45.47
11/10/2009	11/10/2009	$0.335	3.20%	3.24%	$41.42
08/12/2009	08/12/2009	$0.330	3.67%	3.67%	$36.01
05/13/2009	05/13/2009	$0.330	3.84%	3.93%	$33.63
02/11/2009	02/11/2009	$0.330	3.86%	4.04%	$32.65
11/12/2008	11/12/2008	$0.330	3.93%	4.22%	$31.26
08/13/2008	08/13/2008	$0.300	2.44%	2.44%	$49.16
05/14/2008	05/14/2008	$0.300	2.05%	2.12%	$56.73
02/13/2008	02/13/2008	$0.300	2.12%	2.26%	$53.03
11/14/2007	11/14/2007	$0.300	1.96%	2.16%	$55.58
08/15/2007	08/15/2007	$0.263	2.29%	2.29%	$45.88
05/09/2007	05/09/2007	$0.263	2.17%	2.26%	$46.59
02/14/2007	02/14/2007	$0.263	2.12%	2.30%	$45.80
11/15/2006	11/15/2006	$0.263	2.11%	2.39%	$44.00
08/09/2006	08/09/2006	$0.223	2.28%	2.28%	$39.10
05/10/2006	05/10/2006	$0.223	2.02%	2.05%	$43.36
02/15/2006	02/15/2006	$0.223	2.05%	2.12%	$41.93
11/08/2005	11/08/2005	$0.223	2.38%	2.51%	$35.52
08/10/2005	08/10/2005	$0.208	2.44%	2.44%	$34.00
05/11/2005	05/11/2005	$0.208	2.47%	2.49%	$33.29
02/09/2005	02/09/2005	$0.208	2.41%	2.45%	$33.83
11/09/2004	11/09/2004	$0.208	2.40%	2.47%	$33.60
08/11/2004	08/11/2004	$0.200	2.64%	2.64%	$30.28
05/12/2004	05/12/2004	$0.200	2.74%	2.75%	$29.08
02/11/2004	02/11/2004	$0.200	2.44%	2.46%	$32.47
11/12/2003	11/12/2003	$0.200	2.61%	2.65%	$30.25
08/13/2003	08/13/2003	$0.197	3.03%	3.03%	$25.95
05/14/2003	05/14/2003	$0.197	3.23%	3.24%	$24.25
02/12/2003	02/12/2003	$0.197	3.40%	3.43%	$22.94
11/13/2002	11/13/2002	$0.197	3.03%	3.05%	$25.73
08/14/2002	08/14/2002	$0.194	3.25%	3.25%	$23.87
05/15/2002	05/15/2002	$0.194	2.63%	2.64%	$29.37
02/13/2002	02/13/2002	$0.194	2.63%	2.65%	$29.33
11/14/2001	11/14/2001	$0.194	2.87%	2.90%	$26.76
08/15/2001	08/15/2001	$0.192	2.76%	2.76%	$27.75
05/09/2001	05/09/2001	$0.192	2.32%	2.36%	$32.43
02/14/2001	02/14/2001	$0.192	2.10%	2.17%	$35.35
11/15/2000	11/15/2000	$0.192	1.97%	2.07%	$36.97
08/09/2000	08/09/2000	$0.179	2.12%	2.12%	$33.75
05/10/2000	05/10/2000	$0.179	2.55%	2.61%	$27.47
02/16/2000	02/16/2000	$0.179	2.79%	2.93%	$24.44

Page 1 of 1

Dividend Payout Ratio

Tracks the percentage of earnings paid out as dividends each quarter. Lower and stable ratios often indicate safer, more sustainable payouts.

Payout Ratio

Date	Payout Ratio	QoQ Change	YoY Change
2022-10-31	35.8%	N/A	N/A
2023-01-31	38.9%	+8.6%	N/A
2023-04-30	42.7%	+9.8%	N/A
2023-07-31	47.7%	+11.8%	N/A
2023-10-31	54.3%	+13.8%	+51.6%
2024-01-31	55.5%	+2.3%	+42.8%
2024-04-30	56.8%	+2.4%	+33.1%
2024-07-31	58.3%	+2.6%	+22.3%
2024-10-31	59.9%	+2.8%	+10.4%
2025-01-31	57.8%	-3.5%	+4.2%
2025-04-30	55.8%	-3.5%	-1.9%
2025-07-31	53.7%	-3.7%	-7.9%
2025-09-30	29.9%	-44.3%	-50.1%
2025-10-31	29.2%	-2.3%	-49.5%
2025-11-18	29.6%	+1.3%	-46.9%

Dividend to Free Cash Flow Ratio

Shows dividends as a percentage of free cash flow. Consistently high values may signal limited reinvestment capacity or potential dividend risk.

Dividend/FCF Ratio

Date	Dividend/FCF Ratio	QoQ Change	YoY Change
2022-01-31	283.4%	N/A	N/A
2022-04-30	248.5%	-12.3%	N/A
2022-07-31	221.4%	-10.9%	N/A
2022-10-31	199.9%	-9.7%	N/A
2023-01-31	373.2%	+86.7%	+31.7%
2023-04-30	326.3%	-12.6%	+31.3%
2023-07-31	290.1%	-11.1%	+31.0%
2023-10-31	261.2%	-10.0%	+30.7%
2024-01-31	326.7%	+25.1%	-12.5%
2024-04-30	285.6%	-12.6%	-12.5%
2024-07-31	253.9%	-11.1%	-12.5%
2024-10-31	228.6%	-10.0%	-12.5%
2025-01-31	319.9%	+39.9%	-2.1%
2025-04-30	279.5%	-12.6%	-2.2%
2025-07-31	248.2%	-11.2%	-2.3%
2025-09-30	223.3%	-10.0%	-2.4%
2025-10-31	223.3%	+0.0%	-30.2%
2025-11-18	45.6%	-79.6%	-83.7%

Share Price

Historical closing price with range controls. Table view includes quarterâoverâquarter and yearâoverâyear changes for additional context.

EMR Price

Date	Share Price	Price Change	QoQ Change	YoY Change
2016-02-10	$45.77	N/A	N/A	N/A
2016-05-11	$52.86	+$7.09	0.0%	N/A
2016-08-10	$53.44	+$0.58	0.0%	N/A
2016-11-08	$51.33	$-2.11	1.1%	N/A
2017-02-15	$63.73	+$12.40	0.0%	1.1%
2017-05-10	$58.93	$-4.80	0.0%	1.1%
2017-08-09	$60.03	+$1.10	0.0%	1.1%
2017-11-16	$59.02	$-1.01	1.0%	1.0%
2018-02-15	$71.50	+$12.48	0.0%	1.0%
2018-05-10	$71.97	+$0.47	0.0%	1.0%
2018-08-16	$73.96	+$1.99	0.0%	1.0%
2018-11-15	$68.81	$-5.15	1.0%	1.0%
2019-02-14	$66.48	$-2.33	0.0%	1.0%
2019-05-16	$65.66	$-0.82	0.0%	1.0%
2019-08-15	$56.41	$-9.25	0.0%	1.0%
2019-11-14	$72.73	+$16.32	2.0%	2.0%
2020-02-13	$73.14	+$0.41	0.0%	2.0%
2020-05-14	$53.38	$-19.76	0.0%	2.0%
2020-08-13	$70.20	+$16.82	0.0%	2.0%
2020-11-12	$74.23	+$4.03	1.0%	1.0%
2021-02-11	$85.16	+$10.93	0.0%	1.0%
2021-05-13	$94.71	+$9.55	0.0%	1.0%
2021-08-12	$104.11	+$9.40	0.0%	1.0%
2021-11-10	$97.03	$-7.08	2.0%	2.0%
2022-02-10	$96.87	$-0.16	0.0%	2.0%
2022-05-12	$82.75	$-14.12	0.0%	2.0%
2022-08-11	$87.49	+$4.74	0.0%	2.0%
2022-11-09	$90.12	+$2.63	1.0%	1.0%
2023-02-16	$85.70	$-4.42	0.0%	1.0%
2023-05-11	$81.98	$-3.72	0.0%	1.0%
2023-08-10	$95.51	+$13.53	0.0%	1.0%
2023-11-16	$87.50	$-8.01	1.0%	1.0%
2024-02-15	$105.71	+$18.21	0.0%	1.0%
2024-05-16	$112.82	+$7.11	0.0%	1.0%
2024-08-16	$103.09	$-9.73	0.0%	1.0%
2024-11-15	$126.78	+$23.69	0.6%	0.6%
2025-02-14	$123.34	$-3.44	0.0%	0.6%
2025-05-16	$120.61	$-2.73	0.0%	0.6%
2025-08-15	$131.75	+$11.14	0.0%	0.6%
2025-11-14	$127.58	$-4.17	5.1%	5.1%

Price to Earnings

EMR trades at a 128.6x price-to-earnings ratio. This elevated valuation suggests investors expect strong future growth.

2022-01-31	64.7x	N/A	Q-Est
2022-04-30	64.6x	-0.1%	Q-Est
2022-07-31	55.3x	-14.4%	Q-Est
2022-10-31	50.9x	-7.9%	Q-Est
2023-01-31	100.3x	+97.0%	Q-Est
2023-04-30	86.4x	-13.9%	Q-Est
2023-07-31	94.4x	+9.3%	Q-Est
2023-10-31	100.8x	+6.8%	Q-Est
2024-01-31	111.1x	+10.2%	Q-Est
2024-04-30	122.0x	+9.8%	Q-Est
2024-07-31	125.8x	+3.1%	Q-Est
2024-10-31	124.9x	-0.7%	Q-Est
2024-12-31	127.3x	+2.0%	Q
2025-01-31	121.5x	-4.6%	Q-Est
2025-03-31	150.5x	+23.9%	Q
2025-04-30	119.2x	-20.8%	Q-Est
2025-06-30	100.8x	-15.4%	Q
2025-07-31	130.7x	+29.7%	Q-Est
2025-09-30	116.4x	-10.9%	Q
2025-10-31	128.6x	+10.4%	Q-Est

Price to Sales

EMR trades at a 16.4x price-to-sales ratio, providing insight into market valuation relative to revenue generation.

2022-01-31	10.6x	N/A	Q-Est
2022-04-30	10.6x	-0.1%	Q-Est
2022-07-31	9.1x	-14.4%	Q-Est
2022-10-31	8.4x	-7.9%	Q-Est
2023-01-31	14.2x	+69.8%	Q-Est
2023-04-30	12.3x	-13.9%	Q-Est
2023-07-31	13.4x	+9.3%	Q-Est
2023-10-31	14.3x	+6.8%	Q-Est
2024-01-31	12.5x	-12.6%	Q-Est
2024-04-30	13.7x	+9.8%	Q-Est
2024-07-31	14.2x	+3.1%	Q-Est
2024-10-31	14.1x	-0.7%	Q-Est
2024-12-31	17.8x	+27.0%	Q
2025-01-31	15.5x	-13.4%	Q-Est
2025-03-31	16.5x	+6.6%	Q
2025-04-30	15.2x	-7.9%	Q-Est
2025-06-30	13.0x	-14.5%	Q
2025-07-31	16.6x	+28.2%	Q-Est
2025-09-30	15.3x	-8.2%	Q
2025-10-31	16.4x	+7.1%	Q-Est

Revenue

EMR generated $4.5B in revenue.

2022-01-31	$4.91B	N/A	Q-Est
2022-04-30	$4.91B	+0.0%	Q-Est
2022-07-31	$4.91B	+0.0%	Q-Est
2022-10-31	$4.91B	+0.0%	Q-Est
2023-01-31	$3.79B	-22.7%	Q-Est
2023-04-30	$3.79B	+0.0%	Q-Est
2023-07-31	$3.79B	+0.0%	Q-Est
2023-10-31	$3.79B	+0.0%	Q-Est
2024-01-31	$4.37B	+15.3%	Q-Est
2024-04-30	$4.37B	+0.0%	Q-Est
2024-07-31	$4.37B	+0.0%	Q-Est
2024-10-31	$4.37B	+0.0%	Q-Est
2024-12-31	$4.18B	-4.5%	Q
2025-01-31	$4.50B	+7.9%	Q-Est
2025-03-31	$4.43B	-1.6%	Q
2025-04-30	$4.50B	+1.6%	Q-Est
2025-06-30	$4.55B	+1.1%	Q
2025-07-31	$4.50B	-1.1%	Q-Est
2025-09-30	$4.86B	+7.8%	Q
2025-10-31	$4.50B	-7.2%	Q-Est

Net Income

EMR reported $0.6B in net income. Net income has declined by 29% over the period.

2022-01-31	$0.81B	N/A	Q-Est
2022-04-30	$0.81B	+0.0%	Q-Est
2022-07-31	$0.81B	+0.0%	Q-Est
2022-10-31	$0.81B	+0.0%	Q-Est
2023-01-31	$0.54B	-33.4%	Q-Est
2023-04-30	$0.54B	+0.0%	Q-Est
2023-07-31	$0.54B	+0.0%	Q-Est
2023-10-31	$0.54B	+0.0%	Q-Est
2024-01-31	$0.49B	-8.6%	Q-Est
2024-04-30	$0.49B	+0.0%	Q-Est
2024-07-31	$0.49B	+0.0%	Q-Est
2024-10-31	$0.49B	+0.0%	Q-Est
2024-12-31	$0.59B	+18.9%	Q
2025-01-31	$0.57B	-2.0%	Q-Est
2025-03-31	$0.49B	-15.4%	Q
2025-04-30	$0.57B	+18.2%	Q-Est
2025-06-30	$0.59B	+2.2%	Q
2025-07-31	$0.57B	-2.2%	Q-Est
2025-09-30	$0.64B	+11.1%	Q
2025-10-31	$0.57B	-10.0%	Q-Est

Revenue vs Net Income

EMR generated $4.5B in revenue with net income of $0.6B, representing a 12.7% net profit margin.

2022-01-31	$4.91B	$0.81B	Q-Est
2022-04-30	$4.91B	$0.81B	Q-Est
2022-07-31	$4.91B	$0.81B	Q-Est
2022-10-31	$4.91B	$0.81B	Q-Est
2023-01-31	$3.79B	$0.54B	Q-Est
2023-04-30	$3.79B	$0.54B	Q-Est
2023-07-31	$3.79B	$0.54B	Q-Est
2023-10-31	$3.79B	$0.54B	Q-Est
2024-01-31	$4.37B	$0.49B	Q-Est
2024-04-30	$4.37B	$0.49B	Q-Est
2024-07-31	$4.37B	$0.49B	Q-Est
2024-10-31	$4.37B	$0.49B	Q-Est
2024-12-31	$4.18B	$0.59B	Q
2025-01-31	$4.50B	$0.57B	Q-Est
2025-03-31	$4.43B	$0.49B	Q
2025-04-30	$4.50B	$0.57B	Q-Est
2025-06-30	$4.55B	$0.59B	Q
2025-07-31	$4.50B	$0.57B	Q-Est
2025-09-30	$4.86B	$0.64B	Q
2025-10-31	$4.50B	$0.57B	Q-Est

Gross Profit

EMR achieved $3.4B in gross profit, showing revenue after direct production costs.

2022-01-31	$3.20B	N/A	Q-Est
2022-04-30	$3.26B	+1.7%	Q-Est
2022-07-31	$3.27B	+0.4%	Q-Est
2022-10-31	$3.25B	-0.5%	Q-Est
2023-01-31	$2.88B	-11.4%	Q-Est
2023-04-30	$3.04B	+5.7%	Q-Est
2023-07-31	$2.86B	-6.1%	Q-Est
2023-10-31	$3.11B	+8.8%	Q-Est
2024-01-31	$3.47B	+11.5%	Q-Est
2024-04-30	$3.57B	+3.1%	Q-Est
2024-07-31	$3.41B	-4.4%	Q-Est
2024-10-31	$3.32B	-2.7%	Q-Est
2024-12-31	$3.28B	-1.2%	Q-Est
2025-01-31	$3.40B	+3.6%	Q-Est
2025-03-31	$3.59B	+5.7%	Q-Est
2025-04-30	$3.65B	+1.7%	Q-Est
2025-06-30	$3.66B	+0.1%	Q-Est
2025-07-31	$3.72B	+1.7%	Q-Est
2025-09-30	$3.75B	+0.9%	Q-Est
2025-10-31	$3.40B	-9.3%	Q-Est

Operating Income

EMR generated $1.6B in operating income, representing profit from core business operations.

2022-01-31	$1.72B	N/A	Q-Est
2022-04-30	$1.72B	+0.0%	Q-Est
2022-07-31	$1.72B	+0.0%	Q-Est
2022-10-31	$1.72B	+0.0%	Q-Est
2023-01-31	$1.33B	-22.7%	Q-Est
2023-04-30	$1.33B	+0.0%	Q-Est
2023-07-31	$1.33B	+0.0%	Q-Est
2023-10-31	$1.33B	+0.0%	Q-Est
2024-01-31	$1.53B	+15.3%	Q-Est
2024-04-30	$1.53B	+0.0%	Q-Est
2024-07-31	$1.53B	+0.0%	Q-Est
2024-10-31	$1.53B	+0.0%	Q-Est
2024-12-31	$1.46B	-4.5%	Q-Est
2025-01-31	$1.58B	+7.9%	Q-Est
2025-03-31	$1.55B	-1.6%	Q-Est
2025-04-30	$1.58B	+1.6%	Q-Est
2025-06-30	$1.59B	+1.1%	Q-Est
2025-07-31	$1.58B	-1.1%	Q-Est
2025-09-30	$1.70B	+7.8%	Q-Est
2025-10-31	$1.58B	-7.2%	Q-Est

EBITDA

EMR generated $1.8B in EBITDA, measuring operational profitability before interest, taxes, depreciation, and amortization.

2022-01-31	$1.98B	N/A	Q-Est
2022-04-30	$1.98B	+0.0%	Q-Est
2022-07-31	$1.98B	+0.0%	Q-Est
2022-10-31	$1.98B	+0.0%	Q-Est
2023-01-31	$1.53B	-22.7%	Q-Est
2023-04-30	$1.53B	+0.0%	Q-Est
2023-07-31	$1.53B	+0.0%	Q-Est
2023-10-31	$1.53B	+0.0%	Q-Est
2024-01-31	$1.76B	+15.3%	Q-Est
2024-04-30	$1.76B	+0.0%	Q-Est
2024-07-31	$1.76B	+0.0%	Q-Est
2024-10-31	$1.76B	+0.0%	Q-Est
2024-12-31	$1.68B	-4.5%	Q-Est
2025-01-31	$1.81B	+7.9%	Q-Est
2025-03-31	$1.78B	-1.6%	Q-Est
2025-04-30	$1.81B	+1.6%	Q-Est
2025-06-30	$1.83B	+1.1%	Q-Est
2025-07-31	$1.81B	-1.1%	Q-Est
2025-09-30	$1.95B	+7.8%	Q-Est
2025-10-31	$1.81B	-7.2%	Q-Est

Operating Cash Flow

EMR generated $0.7B in operating cash flow, demonstrating the company’s ability to convert earnings into cash.

2022-01-31	$0.93B	N/A	Q-Est
2022-04-30	$0.93B	+0.0%	Q-Est
2022-07-31	$0.93B	+0.0%	Q-Est
2022-10-31	$0.93B	+0.0%	Q-Est
2023-01-31	$0.62B	-33.4%	Q-Est
2023-04-30	$0.62B	+0.0%	Q-Est
2023-07-31	$0.62B	+0.0%	Q-Est
2023-10-31	$0.62B	+0.0%	Q-Est
2024-01-31	$0.57B	-8.6%	Q-Est
2024-04-30	$0.57B	+0.0%	Q-Est
2024-07-31	$0.57B	+0.0%	Q-Est
2024-10-31	$0.57B	+0.0%	Q-Est
2024-12-31	$0.67B	+18.9%	Q-Est
2025-01-31	$0.66B	-2.0%	Q-Est
2025-03-31	$0.56B	-15.4%	Q-Est
2025-04-30	$0.66B	+18.2%	Q-Est
2025-06-30	$0.67B	+2.2%	Q-Est
2025-07-31	$0.66B	-2.2%	Q-Est
2025-09-30	$0.73B	+11.1%	Q-Est
2025-10-31	$0.66B	-10.0%	Q-Est

Free Cash Flow

EMR generated $0.5B in free cash flow. Free cash flow has decreased by 34% over the period.

2022-01-31	$0.76B	N/A	Q-Est
2022-04-30	$0.76B	+0.0%	Q-Est
2022-07-31	$0.76B	+0.0%	Q-Est
2022-10-31	$0.76B	+0.0%	Q-Est
2023-01-31	$0.49B	-35.8%	Q-Est
2023-04-30	$0.49B	+0.0%	Q-Est
2023-07-31	$0.49B	+0.0%	Q-Est
2023-10-31	$0.49B	+0.0%	Q-Est
2024-01-31	$0.41B	-15.1%	Q-Est
2024-04-30	$0.41B	+0.0%	Q-Est
2024-07-31	$0.41B	+0.0%	Q-Est
2024-10-31	$0.41B	+0.0%	Q-Est
2024-12-31	$0.53B	+27.6%	Q-Est
2025-01-31	$0.50B	-4.8%	Q-Est
2025-03-31	$0.40B	-19.7%	Q-Est
2025-04-30	$0.50B	+24.6%	Q-Est
2025-06-30	$0.51B	+2.6%	Q-Est
2025-07-31	$0.50B	-2.5%	Q-Est
2025-09-30	$0.56B	+12.2%	Q-Est
2025-10-31	$0.50B	-10.8%	Q-Est

Free Cash Flow / Share

EMR generates $0.89 in free cash flow per share. FCF per share has declined by 34% over the period.

2022-01-31	$1.35	N/A	Q-Est
2022-04-30	$1.35	+0.0%	Q-Est
2022-07-31	$1.35	+0.0%	Q-Est
2022-10-31	$1.35	+0.0%	Q-Est
2023-01-31	$0.87	-35.8%	Q-Est
2023-04-30	$0.87	+0.0%	Q-Est
2023-07-31	$0.87	+0.0%	Q-Est
2023-10-31	$0.87	+0.0%	Q-Est
2024-01-31	$0.73	-15.1%	Q-Est
2024-04-30	$0.73	+0.0%	Q-Est
2024-07-31	$0.73	+0.0%	Q-Est
2024-10-31	$0.73	+0.0%	Q-Est
2024-12-31	$0.94	+27.6%	Q-Est
2025-01-31	$0.89	-4.8%	Q-Est
2025-03-31	$0.72	-19.7%	Q-Est
2025-04-30	$0.89	+24.6%	Q-Est
2025-06-30	$0.92	+2.6%	Q-Est
2025-07-31	$0.89	-2.5%	Q-Est
2025-09-30	$1.00	+12.2%	Q-Est
2025-10-31	$0.89	-10.8%	Q-Est

Earnings Per Share (EPS)

EMR reported $1.02 in earnings per share. EPS has declined by 29% over the period.

2022-01-31	$1.44	N/A	Q-Est
2022-04-30	$1.44	+0.0%	Q-Est
2022-07-31	$1.44	+0.0%	Q-Est
2022-10-31	$1.44	+0.0%	Q-Est
2023-01-31	$0.96	-33.4%	Q-Est
2023-04-30	$0.96	+0.0%	Q-Est
2023-07-31	$0.96	+0.0%	Q-Est
2023-10-31	$0.96	+0.0%	Q-Est
2024-01-31	$0.88	-8.6%	Q-Est
2024-04-30	$0.88	+0.0%	Q-Est
2024-07-31	$0.88	+0.0%	Q-Est
2024-10-31	$0.88	+0.0%	Q-Est
2024-12-31	$1.04	+18.9%	Q
2025-01-31	$1.02	-2.0%	Q-Est
2025-03-31	$0.86	-15.4%	Q
2025-04-30	$1.02	+18.2%	Q-Est
2025-06-30	$1.04	+2.2%	Q
2025-07-31	$1.02	-2.2%	Q-Est
2025-09-30	$1.13	+11.1%	Q
2025-10-31	$1.02	-10.0%	Q-Est

Return on Equity (ROE)

EMR delivered a 10.6% return on equity, indicating how effectively the company generates returns for shareholders.

2022-01-31	13.7%	N/A	Q-Est
2022-04-30	13.7%	+0.0%	Q-Est
2022-07-31	13.7%	+0.0%	Q-Est
2022-10-31	13.7%	+0.0%	Q-Est
2023-01-31	11.8%	-13.8%	Q-Est
2023-04-30	11.8%	+0.0%	Q-Est
2023-07-31	11.8%	+0.0%	Q-Est
2023-10-31	11.8%	+0.0%	Q-Est
2024-01-31	9.4%	-20.7%	Q-Est
2024-04-30	9.4%	+0.0%	Q-Est
2024-07-31	9.4%	+0.0%	Q-Est
2024-10-31	9.4%	+0.0%	Q-Est
2024-12-31	11.7%	+24.5%	Q-Est
2025-01-31	10.6%	-9.2%	Q-Est
2025-03-31	9.1%	-14.0%	Q-Est
2025-04-30	10.6%	+16.3%	Q-Est
2025-06-30	10.7%	+1.1%	Q-Est
2025-07-31	10.6%	-1.1%	Q-Est
2025-09-30	10.9%	+3.0%	Q-Est
2025-10-31	10.6%	-2.9%	Q-Est

Return on Assets (ROA)

EMR achieved a 6.4% return on assets, measuring how efficiently the company uses its assets to generate profit.

2022-01-31	8.2%	N/A	Q-Est
2022-04-30	8.2%	+0.0%	Q-Est
2022-07-31	8.2%	+0.0%	Q-Est
2022-10-31	8.2%	+0.0%	Q-Est
2023-01-31	7.1%	-13.7%	Q-Est
2023-04-30	7.1%	+0.0%	Q-Est
2023-07-31	7.1%	+0.0%	Q-Est
2023-10-31	7.1%	+0.0%	Q-Est
2024-01-31	5.6%	-20.7%	Q-Est
2024-04-30	5.6%	+0.0%	Q-Est
2024-07-31	5.6%	+0.0%	Q-Est
2024-10-31	5.6%	+0.0%	Q-Est
2024-12-31	7.0%	+24.5%	Q-Est
2025-01-31	6.4%	-9.3%	Q-Est
2025-03-31	5.5%	-14.0%	Q-Est
2025-04-30	6.4%	+16.3%	Q-Est
2025-06-30	6.4%	+1.3%	Q-Est
2025-07-31	6.4%	-1.2%	Q-Est
2025-09-30	6.6%	+3.1%	Q-Est
2025-10-31	6.4%	-3.0%	Q-Est

Net Profit Margin

EMR maintains a 12.7% net profit margin, showing the percentage of revenue retained as profit after all expenses.

2022-01-31	16.5%	N/A	Q-Est
2022-04-30	16.5%	+0.0%	Q-Est
2022-07-31	16.5%	+0.0%	Q-Est
2022-10-31	16.5%	+0.0%	Q-Est
2023-01-31	14.2%	-13.8%	Q-Est
2023-04-30	14.2%	+0.0%	Q-Est
2023-07-31	14.2%	+0.0%	Q-Est
2023-10-31	14.2%	+0.0%	Q-Est
2024-01-31	11.3%	-20.7%	Q-Est
2024-04-30	11.3%	+0.0%	Q-Est
2024-07-31	11.3%	+0.0%	Q-Est
2024-10-31	11.3%	+0.0%	Q-Est
2024-12-31	14.0%	+24.5%	Q
2025-01-31	12.7%	-9.2%	Q-Est
2025-03-31	10.9%	-14.0%	Q
2025-04-30	12.7%	+16.3%	Q-Est
2025-06-30	12.9%	+1.1%	Q
2025-07-31	12.7%	-1.1%	Q-Est
2025-09-30	13.1%	+3.1%	Q
2025-10-31	12.7%	-3.0%	Q-Est

Gross Profit Margin

EMR operates with a 75.5% gross profit margin, reflecting pricing power and cost efficiency in core operations.

2022-01-31	65.3%	N/A	Q-Est
2022-04-30	66.4%	+1.7%	Q-Est
2022-07-31	66.6%	+0.4%	Q-Est
2022-10-31	66.2%	-0.5%	Q-Est
2023-01-31	76.0%	+14.7%	Q-Est
2023-04-30	80.3%	+5.7%	Q-Est
2023-07-31	75.4%	-6.1%	Q-Est
2023-10-31	82.0%	+8.8%	Q-Est
2024-01-31	79.2%	-3.4%	Q-Est
2024-04-30	81.7%	+3.1%	Q-Est
2024-07-31	78.0%	-4.4%	Q-Est
2024-10-31	75.9%	-2.7%	Q-Est
2024-12-31	78.6%	+3.5%	Q
2025-01-31	75.4%	-4.0%	Q-Est
2025-03-31	81.1%	+7.5%	Q
2025-04-30	81.1%	+0.0%	Q-Est
2025-06-30	80.3%	-1.0%	Q
2025-07-31	82.6%	+2.8%	Q-Est
2025-09-30	77.3%	-6.4%	Q
2025-10-31	75.5%	-2.2%	Q-Est

Cash & Debt

EMR holds $0.7B in cash against $0.2B in debt, resulting in a net cash position of $0.5B.

2022-01-31	$0.74B	$0.25B	$0.49B	Q-Est
2022-04-30	$0.74B	$0.25B	$0.49B	Q-Est
2022-07-31	$0.74B	$0.25B	$0.49B	Q-Est
2022-10-31	$0.74B	$0.25B	$0.49B	Q-Est
2023-01-31	$0.57B	$0.19B	$0.38B	Q-Est
2023-04-30	$0.57B	$0.19B	$0.38B	Q-Est
2023-07-31	$0.57B	$0.19B	$0.38B	Q-Est
2023-10-31	$0.57B	$0.19B	$0.38B	Q-Est
2024-01-31	$0.66B	$0.22B	$0.44B	Q-Est
2024-04-30	$0.66B	$0.22B	$0.44B	Q-Est
2024-07-31	$0.66B	$0.22B	$0.44B	Q-Est
2024-10-31	$0.66B	$0.22B	$0.44B	Q-Est
2024-12-31	$0.63B	$0.21B	$0.42B	Q-Est
2025-01-31	$0.68B	$0.23B	$0.45B	Q-Est
2025-03-31	$0.66B	$0.22B	$0.44B	Q-Est
2025-04-30	$0.68B	$0.23B	$0.45B	Q-Est
2025-06-30	$0.68B	$0.23B	$0.46B	Q-Est
2025-07-31	$0.68B	$0.23B	$0.45B	Q-Est
2025-09-30	$0.73B	$0.24B	$0.49B	Q-Est
2025-10-31	$0.68B	$0.23B	$0.45B	Q-Est

Shares Outstanding

EMR has 0.6B shares outstanding.

2022-01-31	0.56B	N/A	Q-Est
2022-04-30	0.56B	+0.0%	Q-Est
2022-07-31	0.56B	+0.0%	Q-Est
2022-10-31	0.56B	+0.0%	Q-Est
2023-01-31	0.56B	+0.0%	Q-Est
2023-04-30	0.56B	+0.0%	Q-Est
2023-07-31	0.56B	+0.0%	Q-Est
2023-10-31	0.56B	+0.0%	Q-Est
2024-01-31	0.56B	+0.0%	Q-Est
2024-04-30	0.56B	+0.0%	Q-Est
2024-07-31	0.56B	+0.0%	Q-Est
2024-10-31	0.56B	+0.0%	Q-Est
2024-12-31	0.56B	+0.0%	Q-Est
2025-01-31	0.56B	+0.0%	Q-Est
2025-03-31	0.56B	+0.0%	Q-Est
2025-04-30	0.56B	+0.0%	Q-Est
2025-06-30	0.56B	+0.0%	Q-Est
2025-07-31	0.56B	+0.0%	Q-Est
2025-09-30	0.56B	+0.0%	Q-Est
2025-10-31	0.56B	+0.0%	Q-Est

Stock-Based Comp

EMR reported $0.1B in stock-based compensation.

2022-01-31	$0.12B	N/A	Q-Est
2022-04-30	$0.12B	+0.0%	Q-Est
2022-07-31	$0.12B	+0.0%	Q-Est
2022-10-31	$0.12B	+0.0%	Q-Est
2023-01-31	$0.09B	-22.7%	Q-Est
2023-04-30	$0.09B	+0.0%	Q-Est
2023-07-31	$0.09B	+0.0%	Q-Est
2023-10-31	$0.09B	+0.0%	Q-Est
2024-01-31	$0.11B	+15.3%	Q-Est
2024-04-30	$0.11B	+0.0%	Q-Est
2024-07-31	$0.11B	+0.0%	Q-Est
2024-10-31	$0.11B	+0.0%	Q-Est
2024-12-31	$0.10B	-4.5%	Q-Est
2025-01-31	$0.11B	+7.9%	Q-Est
2025-03-31	$0.11B	-1.6%	Q-Est
2025-04-30	$0.11B	+1.6%	Q-Est
2025-06-30	$0.11B	+1.1%	Q-Est
2025-07-31	$0.11B	-1.1%	Q-Est
2025-09-30	$0.12B	+7.8%	Q-Est
2025-10-31	$0.11B	-7.2%	Q-Est

FCF vs Stock Based Comp

EMR generated $0.5B in free cash flow while spending $0.1B on stock-based compensation, representing 22% of FCF.

2022-01-31	$0.76B	$0.12B	Q-Est
2022-04-30	$0.76B	$0.12B	Q-Est
2022-07-31	$0.76B	$0.12B	Q-Est
2022-10-31	$0.76B	$0.12B	Q-Est
2023-01-31	$0.49B	$0.09B	Q-Est
2023-04-30	$0.49B	$0.09B	Q-Est
2023-07-31	$0.49B	$0.09B	Q-Est
2023-10-31	$0.49B	$0.09B	Q-Est
2024-01-31	$0.41B	$0.11B	Q-Est
2024-04-30	$0.41B	$0.11B	Q-Est
2024-07-31	$0.41B	$0.11B	Q-Est
2024-10-31	$0.41B	$0.11B	Q-Est
2024-12-31	$0.53B	$0.10B	Q-Est
2025-01-31	$0.50B	$0.11B	Q-Est
2025-03-31	$0.40B	$0.11B	Q-Est
2025-04-30	$0.50B	$0.11B	Q-Est
2025-06-30	$0.51B	$0.11B	Q-Est
2025-07-31	$0.50B	$0.11B	Q-Est
2025-09-30	$0.56B	$0.12B	Q-Est
2025-10-31	$0.50B	$0.11B	Q-Est

FCF vs FCF / Share

EMR reported $0.5B in free cash flow, translating to $0.89 per share.

2022-01-31	$0.76B	$1.35	Q-Est
2022-04-30	$0.76B	$1.35	Q-Est
2022-07-31	$0.76B	$1.35	Q-Est
2022-10-31	$0.76B	$1.35	Q-Est
2023-01-31	$0.49B	$0.87	Q-Est
2023-04-30	$0.49B	$0.87	Q-Est
2023-07-31	$0.49B	$0.87	Q-Est
2023-10-31	$0.49B	$0.87	Q-Est
2024-01-31	$0.41B	$0.73	Q-Est
2024-04-30	$0.41B	$0.73	Q-Est
2024-07-31	$0.41B	$0.73	Q-Est
2024-10-31	$0.41B	$0.73	Q-Est
2024-12-31	$0.53B	$0.94	Q-Est
2025-01-31	$0.50B	$0.89	Q-Est
2025-03-31	$0.40B	$0.72	Q-Est
2025-04-30	$0.50B	$0.89	Q-Est
2025-06-30	$0.51B	$0.92	Q-Est
2025-07-31	$0.50B	$0.89	Q-Est
2025-09-30	$0.56B	$1.00	Q-Est
2025-10-31	$0.50B	$0.89	Q-Est

Revenue: Actual + Estimates

This chart tracks EMR revenue: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

2024-12-31	$4.17B	Actual	Q
2024-12-31	$4.09B	Estimate	Q
2025-01-31	$4.50B	Actual	Q-Est
2025-01-31	$4.41B	Estimate	Q-Est
2025-03-31	$4.43B	Actual	Q
2025-03-31	$4.34B	Estimate	Q
2025-04-30	$4.43B	Actual	Q
2025-04-30	$4.34B	Estimate	Q
2025-06-30	$4.55B	Actual	Q
2025-06-30	$4.46B	Estimate	Q
2025-07-31	$4.50B	Actual	Q-Est
2025-07-31	$4.41B	Estimate	Q-Est
2025-09-30	$4.86B	Actual	Q
2025-09-30	$4.76B	Estimate	Q
2025-10-31	$4.50B	Actual	Q-Est
2025-10-31	$4.36B	Estimate	Q-Est
2026-01-31	$4.48B	Projection	F
2026-04-30	$4.45B	Projection	F
2026-07-31	$4.43B	Projection	F
2026-10-31	$4.40B	Projection	F

EPS: Actual + Estimates

This chart tracks EMR eps: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

2024-12-31	$0.88	Actual	Q-Est
2024-12-31	$1.28	Estimate	Q-Est
2025-01-31	$1.04	Actual	Q
2025-01-31	$1.28	Estimate	Q
2025-03-31	$1.04	Actual	Q
2025-03-31	$1.28	Estimate	Q
2025-04-30	$1.02	Actual	Q-Est
2025-04-30	$1.41	Estimate	Q-Est
2025-06-30	$1.02	Actual	Q-Est
2025-06-30	$1.51	Estimate	Q-Est
2025-07-31	$1.04	Actual	Q
2025-07-31	$1.51	Estimate	Q
2025-09-30	$1.02	Actual	Q-Est
2025-09-30	$1.62	Estimate	Q-Est
2025-10-31	$1.13	Actual	Q
2025-10-31	$1.62	Estimate	Q
2026-01-31	$1.11	Projection	F
2026-04-30	$1.08	Projection	F
2026-07-31	$1.06	Projection	F
2026-10-31	$1.03	Projection	F

Net Income: Actual + Estimates

This chart tracks EMR net income: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

2024-12-31	$0.49B	Actual	Q-Est
2024-12-31	$0.72B	Estimate	Q-Est
2025-01-31	$0.58B	Actual	Q
2025-01-31	$0.72B	Estimate	Q
2025-03-31	$0.58B	Actual	Q
2025-03-31	$0.72B	Estimate	Q
2025-04-30	$0.57B	Actual	Q-Est
2025-04-30	$0.79B	Estimate	Q-Est
2025-06-30	$0.57B	Actual	Q-Est
2025-06-30	$0.85B	Estimate	Q-Est
2025-07-31	$0.59B	Actual	Q
2025-07-31	$0.85B	Estimate	Q
2025-09-30	$0.57B	Actual	Q-Est
2025-09-30	$0.91B	Estimate	Q-Est
2025-10-31	$0.64B	Actual	Q
2025-10-31	$0.91B	Estimate	Q
2026-01-31	$0.62B	Projection	F
2026-04-30	$0.60B	Projection	F
2026-07-31	$0.59B	Projection	F
2026-10-31	$0.58B	Projection	F

EBITDA: Actual + Estimates

This chart tracks EMR ebitda: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

2024-12-31	$1.76B	Actual	Q
2024-12-31	$1.65B	Estimate	Q
2025-01-31	$1.68B	Actual	Q-Est
2025-01-31	$1.78B	Estimate	Q-Est
2025-03-31	$1.68B	Actual	Q
2025-03-31	$1.75B	Estimate	Q
2025-04-30	$1.81B	Actual	Q
2025-04-30	$1.75B	Estimate	Q
2025-06-30	$1.81B	Actual	Q
2025-06-30	$1.80B	Estimate	Q
2025-07-31	$1.83B	Actual	Q-Est
2025-07-31	$1.78B	Estimate	Q-Est
2025-09-30	$1.81B	Actual	Q
2025-09-30	$1.92B	Estimate	Q
2025-10-31	$1.95B	Actual	Q-Est
2025-10-31	$1.75B	Estimate	Q-Est
2026-01-31	$1.80B	Projection	F
2026-04-30	$1.79B	Projection	F
2026-07-31	$1.78B	Projection	F
2026-10-31	$1.77B	Projection	F

Disclaimer: The information on this page is for educational and entertainment purposes only and does not constitute financial advice. Do your own research and consult a qualified financial advisor before making investment decisions. Data sources include Yahoo Finance and other third-party providers and may contain errors or delays.

EMR – Dividend Returns, History & Calculator

Company Info

Price Data

Dividend Data

Growth Rates

Total Returns

Fair Value

Financial Metrics

Calculate your EMR Dividend Returns

Portfolio Growth Over Time

Year-by-Year Portfolio Growth (Realistic DRIP Scenario)

EMR Dividend History

EMR 10-yr Total Return ($10,000 invested)

Total Return with and without DRIP (EMR)

EMR Dividend Reinvestment Snowball

After 20 Years

After 30 Years

Milestones on the way

How we estimate these numbers

Projected Future Returns & Dividends for EMR

Estimated Future Value + Dividends – EMR

Dividend History: Payments & Yield

Dividend Growth

Dividend Payments & Yield

EMR Dividend History

Dividend Payout Ratio

Dividend to Free Cash Flow Ratio

Share Price

Price to Earnings

Price to Sales

Revenue

Net Income

Revenue vs Net Income

Gross Profit

Operating Income

EBITDA

Operating Cash Flow

Free Cash Flow

Free Cash Flow / Share

Earnings Per Share (EPS)

Return on Equity (ROE)

Return on Assets (ROA)

Net Profit Margin

Gross Profit Margin

Cash & Debt

Shares Outstanding

Stock-Based Comp

FCF vs Stock Based Comp

FCF vs FCF / Share

Revenue: Actual + Estimates

EPS: Actual + Estimates

Net Income: Actual + Estimates

EBITDA: Actual + Estimates

Other Articles of Interest

Related stocks

Download now

Get your dividend champions spreadsheet.